OSI Systems Reports Fiscal 2023 First Quarter Financial Results
OSI Systems reported Q1 revenues of $268.1 million, a 4% decrease year-over-year. Net income also fell to $11.2 million or $0.65 per diluted share, down from $19.1 million or $1.04 per share in the same quarter last year. The company noted a record backlog of $1.3 billion and reiterated its FY 2023 guidance, projecting 7% - 11% revenue growth and 17% - 22% adjusted EPS growth for the remaining quarters. Operating cash flow improved significantly to $17.2 million, reversing negative cash flow from the prior year.
- Record backlog of $1.3 billion indicates strong future opportunities.
- Operating cash flow improved to $17.2 million, up from negative $11.0 million last year.
- Healthcare division focusing on new product development in patient monitoring.
- Q1 revenues decreased by 4% compared to the previous year.
- Net income decreased to $11.2 million, down 41% year-over-year.
-
Q1 Revenues of
$268 Million -
Q1 Earnings Per Diluted Share
-
GAAP EPS of
$0.65 -
Adjusted EPS of
$0.87
-
GAAP EPS of
-
Record Q1 Ended Backlog of
$1.3 Billion -
Company Reiterates FY 2023 Guidance
-
Q2-Q4 Year-Over-Year Revenue Growth of
7% -11% -
Q2-Q4 Year-Over-Year Adjusted EPS Growth of
17% -22%
-
Q2-Q4 Year-Over-Year Revenue Growth of
For the first quarter of fiscal 2023, the Company reported revenues of
For the three months ended
The Company utilized its credit facility to repurchase and retire its outstanding convertible notes, which matured on
Fiscal Year 2023 Outlook
The Company is reiterating its fiscal 2023 guidance of
The Company’s fiscal 2023 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for adjusted diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of adjusted diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected adjusted diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for the three months ended
Reconciliations of GAAP financial information to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, and operational performance in fiscal 2023 and beyond. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; the impact of the
|
|||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
(in thousands, except per share data) |
|||||||
|
|
||||||
|
Three Months Ended
|
||||||
|
2021 |
|
2022 |
||||
|
|
|
|
||||
Revenues: |
|
|
|
||||
Products |
$ |
207,212 |
|
|
$ |
196,954 |
|
Services |
72,045 |
|
|
71,117 |
|
||
Total net revenues |
279,257 |
|
|
268,071 |
|
||
Cost of goods sold: |
|
|
|
||||
Products |
142,906 |
|
|
143,369 |
|
||
Services |
37,021 |
|
|
37,205 |
|
||
Total cost of goods sold |
179,927 |
|
|
180,574 |
|
||
Gross profit |
99,330 |
|
|
87,497 |
|
||
Operating expenses: |
|
|
|
||||
Selling, general and administrative |
57,323 |
|
|
53,438 |
|
||
Research and development |
14,817 |
|
|
14,540 |
|
||
Impairment, restructuring and other charges, net |
2,510 |
|
|
1,219 |
|
||
Total operating expenses |
74,650 |
|
|
69,197 |
|
||
Income from operations |
24,680 |
|
|
18,300 |
|
||
Interest and other expense, net |
(2,016 |
) |
|
(3,432 |
) |
||
Income before income taxes |
22,664 |
|
|
14,868 |
|
||
Provision for income taxes |
(3,612 |
) |
|
(3,633 |
) |
||
Net income |
$ |
19,052 |
|
|
$ |
11,235 |
|
|
|
|
|
||||
Diluted earnings per share |
$ |
1.04 |
|
|
$ |
0.65 |
|
Weighted average shares outstanding – diluted |
18,306 |
|
|
17,180 |
|
UNAUDITED SEGMENT INFORMATION |
|||||||
(in thousands) |
|||||||
|
|
||||||
|
Three Months Ended
|
||||||
|
2021 |
|
2022 |
||||
Revenues – by Segment: |
|
|
|
||||
Security division |
$ |
149,517 |
|
|
$ |
144,993 |
|
Healthcare division |
50,588 |
|
|
43,563 |
|
||
Optoelectronics and Manufacturing division, including intersegment revenues |
92,305 |
|
|
93,915 |
|
||
Intersegment eliminations |
(13,153 |
) |
|
(14,400 |
) |
||
Total |
$ |
279,257 |
|
|
$ |
268,071 |
|
|
|
|
|
||||
Operating income (loss) – by Segment: |
|
|
|
||||
Security division |
$ |
21,593 |
|
|
$ |
14,925 |
|
Healthcare division |
5,920 |
|
|
1,628 |
|
||
Optoelectronics and Manufacturing division |
9,783 |
|
|
11,258 |
|
||
Corporate |
(12,463 |
) |
|
(10,148 |
) |
||
Intersegment eliminations |
(153 |
) |
|
637 |
|
||
Total |
$ |
24,680 |
|
|
$ |
18,300 |
|
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(in thousands) |
|||||
|
|
|
|
||
Assets |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
64,202 |
|
$ |
53,990 |
Accounts receivable, net |
|
307,973 |
|
|
313,506 |
Inventories |
|
333,907 |
|
|
361,949 |
Other current assets |
|
40,062 |
|
|
41,599 |
Total current assets |
|
746,144 |
|
|
771,044 |
Property and equipment, net |
|
109,684 |
|
|
107,976 |
|
|
336,357 |
|
|
335,825 |
Intangible assets, net |
|
138,370 |
|
|
138,202 |
Other non-current assets |
|
112,595 |
|
|
114,720 |
Total Assets |
$ |
1,443,150 |
|
$ |
1,467,767 |
|
|
|
|
||
Liabilities and Stockholders' Equity |
|
|
|
||
|
|
|
|
||
Bank lines of credit |
$ |
60,000 |
|
$ |
215,000 |
Current portion of long-term debt |
|
244,575 |
|
|
8,110 |
Accounts payable and accrued expenses |
|
194,266 |
|
|
207,586 |
Other current liabilities |
|
115,113 |
|
|
131,785 |
Total current liabilities |
|
613,954 |
|
|
562,481 |
Long-term debt |
|
48,668 |
|
|
143,150 |
Other long-term liabilities |
|
142,104 |
|
|
137,483 |
Total liabilities |
|
804,726 |
|
|
843,114 |
Total stockholders’ equity |
|
638,424 |
|
|
624,653 |
Total Liabilities and Stockholders’ Equity |
$ |
1,443,150 |
|
$ |
1,467,767 |
RECONCILIATION OF GAAP TO NON-GAAP | |||||||||||||||
NET INCOME AND EARNINGS PER SHARE |
|||||||||||||||
(in thousands, except earnings per share data) |
|||||||||||||||
|
Three Months Ended |
||||||||||||||
|
2021 |
|
2022 |
||||||||||||
|
Net income |
|
Diluted EPS |
|
Net income |
|
Diluted EPS |
||||||||
GAAP basis |
$ |
19,052 |
|
|
$ |
1.04 |
|
|
$ |
11,235 |
|
|
$ |
0.65 |
|
Impairment, restructuring and other charges, net |
|
2,510 |
|
|
|
0.14 |
|
|
|
1,219 |
|
|
|
0.07 |
|
Amortization of acquired intangible assets |
|
3,198 |
|
|
|
0.18 |
|
|
|
3,720 |
|
|
|
0.22 |
|
Non-cash interest expense |
|
68 |
|
|
|
0.00 |
|
|
|
156 |
|
|
|
0.01 |
|
Tax effect of above adjustments |
|
(1,467 |
) |
|
|
(0.08 |
) |
|
|
(1,279 |
) |
|
|
(0.07 |
) |
Discrete tax items |
|
(2,145 |
) |
|
|
(0.12 |
) |
|
|
(99 |
) |
|
|
(0.01 |
) |
Non-GAAP basis |
$ |
21,216 |
|
|
$ |
1.16 |
|
|
$ |
14,952 |
|
|
$ |
0.87 |
|
RECONCILIATION OF GAAP TO NON-GAAP |
||||||||||||||||||||||||||||
OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT |
||||||||||||||||||||||||||||
(in thousands, except percentages) |
||||||||||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
21,593 |
|
14.4 |
% |
|
$ |
5,920 |
|
11.7 |
% |
|
$ |
9,783 |
|
10.6 |
% |
|
$ |
(12,616 |
) |
|
$ |
24,680 |
|
8.8 |
% |
Impairment, restructuring and other charges, net |
|
|
275 |
|
0.2 |
% |
|
|
- |
|
- |
|
|
|
- |
|
- |
|
|
|
2,235 |
|
|
|
2,510 |
|
0.9 |
% |
Amortization of acquired intangible assets |
|
|
2,286 |
|
1.6 |
% |
|
|
202 |
|
0.4 |
% |
|
|
710 |
|
0.8 |
% |
|
|
- |
|
|
|
3,198 |
|
1.2 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
24,154 |
|
16.2 |
% |
|
$ |
6,122 |
|
12.1 |
% |
|
$ |
10,493 |
|
11.4 |
% |
|
$ |
(10,381 |
) |
|
$ |
30,388 |
|
10.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Three Months Ended |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Healthcare Division |
|
Optoelectronics and Manufacturing Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
14,925 |
|
10.3 |
% |
|
$ |
1,628 |
|
3.7 |
% |
|
$ |
11,258 |
|
12.0 |
% |
|
$ |
(9,511 |
) |
|
$ |
18,300 |
|
6.8 |
% |
Impairment, restructuring and other charges, net |
|
|
788 |
|
0.5 |
% |
|
|
294 |
|
0.7 |
% |
|
|
15 |
|
0.0 |
% |
|
|
122 |
|
|
|
1,219 |
|
0.5 |
% |
Amortization of acquired intangible assets |
|
|
2,820 |
|
2.0 |
% |
|
|
202 |
|
0.5 |
% |
|
|
698 |
|
0.7 |
% |
|
|
- |
|
|
|
3,720 |
|
1.4 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
18,533 |
|
12.8 |
% |
|
$ |
2,124 |
|
4.9 |
% |
|
$ |
11,971 |
|
12.7 |
% |
|
$ |
(9,389 |
) |
|
$ |
23,239 |
|
8.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005374/en/
Vice President, Business Development
Tel: (310) 349-2237
avashishat@osi-systems.com
Source:
FAQ
What were OSI Systems' Q1 2023 earnings results?
How does OSI Systems' backlog affect future revenue growth?
What is OSI Systems' guidance for FY 2023?
Why did OSI Systems' Q1 revenue decline?